Completed NA INTERVENTIONAL 1-arm NCT01009008

Patient Activated Controlled Expansion (PACE) Trial (PACE)

Patient Activated Controlled Expansion (PACE) for Breast Reconstruction Utilizing Controlled CO2 Inflation

Sponsor: AirXpanders, Inc.

Conditions Breast Cancer Breast Reconstruction Mastectomy

Interventions Patient Activated Controlled Expansion Device

Updated 6 times since 2017 Last updated: Aug 8, 2018 Started: Jun 30, 2009 Primary completion: May 31, 2013 Completion: Jun 30, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Breast Cancer and Breast Reconstruction and is currently completed. AirXpanders, Inc. leads this study, which shows 6 recorded versions since 2009 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Sep 2018 — Jan 2021 [monthly]

Completed NA
Jun 2018 — Sep 2018 [monthly]

Completed NA

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Jun 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

AirXpanders, Inc.

Data source: AirXpanders, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Perth, Australia